J. Appl. Cryst.の発刊に際して

Controlled/living radical polymerization: Features, developments, and perspectives

4.2. Solid-Supported Electrolytes 2280 4.3. Solid-Supported Mediators 2282 4.4. Supported Substrate-Product Capture 2283 4.5. A Unique Electrolyte/Solvent System 2285 5. Reaction Conditions 2285 5.1. Supercritical Fluids 2285 5.1.1. Electrochemical Properties of scCO2 2285 5.1.2. Electroreductive Carboxylation in scCO2 2286 5.1.3. Electrochemical Polymerization in scCO2 2286 5.2. The Cation-Pool Method 2286 5.2.1. Generation of N-Acyliminium Ion Pools 2286 5.2.2. Generation of Alkoxycarbenium Ion Pools 2287 5.2.3. Generation of Diarylcarbenium Ion Pools 2288 5.2.4. Generation of Other Cation Pools 2289 6. Electrochemical Devices 2289 6.1. Electrode Materials 2289 6.2. Ultrasound and Centrifugal Fields 2290 6.3. Electrochemical Microflow Systems 2290 7. Combinatorial Electrochemical Synthesis 2292 7.1. Parallel Electrolysis Using a Macrosystem 2292 7.2. Parallel Electrolysis Using a Microsystem 2293 7.3. Serial Electrolysis Using a Microsystem 2294 8. Conclusions 2294 9. Acknowledgments 2294 10. References 2294

Modern Strategies in Electroorganic Synthesis

Molecular imaging is the visualization, characterization and measurement of biological processes at the molecular and cellular levels in humans and other living systems. Molecular imaging agents are probes used to visualize, characterize and measure biological processes in living systems. These two definitions were put forth by the Sociey of Nuclear Medicine (SNM) in 2007 as a way to capture the interdisciplinary nature of this relatively new field. The emergence of molecular imaging as a scientific discipline is a result of advances in chemistry, biology, physics and engineering, and the application of imaging probes and technologies has reshaped the philosophy of drug discovery in the pharmaceutical sciences by providing more cost effective ways to evaluate the efficacy of a drug candidate and allowing pharmaceutical companies to reduce the time it takes to introduce new therapeutics to the marketplace. Finally the impact of molecular imaging on clinical medicine has been extensive since it allows a physician to diagnose a patient’s illness, prescribe treatment and monitor the efficacy of that treatment non-invasively.

Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) were the first molecular imaging modalities used clinically. SPECT requires the use of a contrast agent labeled with a gamma emitting radionuclide, which should have an ideal gamma energy of 100-250 keV. These gamma rays are recorded by the detectors of a dedicated gamma camera or SPECT instrument and after signal processing can be converted into an image indentifying the localization of the radiotracer. PET requires the injected radiopharmaceutical to be labeled with a positron emitting radionuclide. As the radionuclide decays it ejects a positron from its nucleus which travels a short distance before being annihilated with an electron to release two 511 keV gamma rays 180° apart that are detected by the PET scanner (Figure 1). After sufficient acquisition time the data are reconstructed using computer based algorithms to yield images of the radiotracer’s location within the organism. When compared to SPECT, PET has greater advantages with respect to sensitivity and resolution and has been gaining in clinical popularity, with the number of PET-based studies expected to reach 3.2 million by 2010.1 While SPECT and PET technology has been around for decades, its use remained limited because of the limited availability of relevant isotopes which had to be produced in nuclear reactors or particle accelerators. However, the introduction of the small biomedical cyclotron, the self-contained radionuclide generator and the dedicated small animal or clinical SPECT and PET scanners to hospitals and research facilities has increased the demand for SPECT and PET isotopes.



Figure 1

Cartoon depicting the fundamental principle of Positron Emission Tomography (PET). As the targeting group interacts with the cell surface receptor, the positron emitting radio-metal decays by ejecting β+ particles from its nucleus. After traveling ...



Traditional PET isotopes such as 18F, 15O, 13N and 11C have been developed for incorporation into small molecules, but due to their often lengthy radio-syntheses, short half-lives and rapid clearance, only early time points were available for imaging, leaving the investigation of biological processes, which occur over the duration of hours or days, difficult to explore. With the continuing development of biological targeting agents such as proteins, peptides, antibodies and nanoparticles, which demonstrate a range of biological half-lives, a need arose to produce new radionuclides with half-lives complementary with their biological properties. As a result, the production and radiochemistry of radiometals such as Zr, Y, In, Ga and Cu have been investigated as radionuclide labels for biomolecules since they have the potential to combine their favorable decay characteristics with the biological characteristics of the targeting molecule to become a useful radiopharmaceutical (Tables ​(Tables11 and ​and22).2



Table 1

Gamma- and Beta-Emitting Radiometals





Table 2

Positron-Emitting Radiometals



The number of papers published describing the production or use of these radiometals continues to expand rapidly, and in recognition of this fact, the authors have attempted to present a comprehensive review of this literature as it relates to the production, ligand development and radiopharmaceutical applications of radiometals (excluding 99mTc) since 1999. While numerous reviews have appeared describing certain aspects of the production, coordination chemistry or application of these radiometals,2-18 very few exhaustive reviews have been published.10,12 Additionally, this review has been written to be used as an individual resource or as a companion resource to the review written by Anderson and Welch in 1999.12 Together, they provide a literature survey spanning 50 years of scientific discovery. To accomplish this goal, this review has been organized into three sections: the first section discusses the coordination chemistry of the metal ions Zr, Y, In, Ga and Cu and their chelators in the context of radiopharmaceutical development; the second section describes the methods used to produce Zr, Y, In, Ga and Cu radioisotopes; and the final section describes the application of these radiometals in diagnostic imaging and radiotherapy.

/pdf/coordinating-radiometals-of-copper-gallium-indium-yttrium-3clup681fj.pdf

Coordinating Radiometals of Copper, Gallium, Indium, Yttrium and Zirconium for PET and SPECT Imaging of Disease

Main group metal complexes of semicarbazones and thiosemicarbazones. A structural review

Cross-bridged cyclam. Protonation and lithium cation (Li+) complexation in a diamond-lattice cleft

Structural studies of three isomeric forms of heterocyclic N(4)-substituted thiosemicarbazones and two nickel(II) complexes

Structures of nickel(II) and copper(II) complexes of 2-acetylpyridine azacyclothiosemicarbazones

Deformation de la microstructure (trois modes possibles) par diffusion RX aux petits angles

Deformation of microphase structures in segmented polyurethanes

A series of vanadium(III) and -(IV) complexes of the type [L 2 V]BPh 4 , [LVCl 2 DMF], [LVOCIDMF], and [LVO(acac)] where L is either the anion of hydridotris(pyrazolyl)borate, HB(pz) 3 , or hydridotris(3,5-dimethylpyrazolyl)borate, HB(Me 2 pz) 3 , have been synthesized and characterized by elemental analysis, molar conductance, electrochemistry, magnetic, UV-vis, IR, and ESR techniques. In all cases, the metal ion is in a distorted octahedral environment

Jerry P. Jasinski

Papers

Cross-bridged cyclam. Protonation and lithium cation (Li+) complexation in a diamond-lattice cleft

Structural studies of three isomeric forms of heterocyclic N(4)-substituted thiosemicarbazones and two nickel(II) complexes

Structures of nickel(II) and copper(II) complexes of 2-acetylpyridine azacyclothiosemicarbazones

Deformation of microphase structures in segmented polyurethanes

Synthesis, structure, and spectroscopic properties of vanadium(III) and -(IV) complexes containing hydridotris(pyrazolyl)borate ligands. 3